Abstract
The transcriptional regulatory factor PU.1 is important for the regulation of a diverse group of hematopoietic and myeloid genes. Posttranslational phosphorylation of PU.1 has been demonstrated in the regulation of a variety of promoters in normal cells. In leukemia cells, differing patterns of PU.1 phosphorylation have been described among acute myelogenous leukemia (AML) subtypes. Therefore, we hypothesized that modulation of PU.1-dependent gene expression might be a molecular mediator of alterations in myeloid cell growth and differentiation that have been demonstrated to be early events in benzene-induced leukemogenesis. We found that freshly isolated human CD34+ hematopoietic progenitor cells (HPC) exhibit multiple PU.1-DNA binding species that represent PU.1 proteins in varying degrees of phosphorylation states as determined by phosphatase treatment in combination with electrophoretic mobility shift assay (EMSA). Maturation of granulocyte and monocyte lineages is also accompanied by distinct changes in PU.1-DNA binding patterns. Experiments reveal that increasing doses of the benzene metabolite, hydroquinone (HQ) induce a time-and dose-dependent alteration in the pattern of PU.1-DNA binding in cultured human CD34+ cells, corresponding to hyperphosphorylation of the PU.1 protein. HQ-induced alterations in PU.1-DNA binding are concomitant with a sustained immature CD34+ phenotype and cytokine-dependent enhanced clonogenic activity in cultured human HPC. These results suggest that HQ induces a dysregulation in the external signals modulating PU.1 protein phosphorylation and this dysregulation may be an early event in the generation of benzene-induced AML.
Similar content being viewed by others
Abbreviations
- ADCC:
-
antibody dependent cell-mediated cytotoxicity
- C/EBP:
-
ccaat/enhancer binding protein
- CFU:
-
colony-forming unit
- FITC:
-
fluorescein isothiocyanate
- G-CSF:
-
granulocyte colony-stimulating factor
- GM-CFU:
-
granulocyte/macrophage colony-forming units
- GM-CSF:
-
granulocyte/macrophage colony-stimulating factor
- HQ:
-
hydroquinone
- IL-3:
-
interleukin 3
- M-CSF:
-
macrophage colony-stimulating factor
- MNC:
-
mononuclear cells
- NF-κB:
-
nuclear factor kappa B
- PAP assay:
-
potato acid phosphatase assay
- PE:
-
phycoerythrin
- PerCp:
-
peridinin chlorophyll protein
- pRb:
-
retinoblastoma protein
- SCF:
-
stem cell factor
- TBP:
-
TATA-binding protein
References
Behre G, Whitmarsh AJ, Coghlan MP, et al. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem. 1999;274:4939–46.
Borregaard N, Theilgaard-Monch K, Sorensen OE, Cowland JB. Regulation of human neutrophil granule protein expression. Curr Opin Hematol. 2001;8:23–7.
Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368–76.
Carey JO, Posekany KJ, deVente JE, Pettit GR, Ways DK. Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition. Blood. 1996;87:4316–24.
Celada A, Borras FE, Soler C, et al. The transcription factor PU.1 is involved in macrophage proliferation. J Exp Med. 1996;184:61–9.
Colagiovanni DB, Stillman WS, Irons RD. Chemical suppression of a subpopulation of primitive hematopoietic progenitor cells: 1,3-butadiene produces a hematopoietic defect similar to Steel or White Spotted mutations in mice. Proc Natl Acad Sci USA. 1993;90:2803–6.
Cronkite EP, Drew RT, Inoue T, Hirabayashi Y, Bullis JE, Hematotoxicity and carcinogenicity of inhaled benzene. Environ Health Perspect 1989;82:97–108.
Cuneo A, Fagioli F, Pazzi I, et al. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leuk Res. 1992;16:789–96.
Dahl R, Simon MC. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Blood Cells Mol Dis. 2003;31:229–33.
DeKoter RP, Walsh JC, Singh H. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/ macrophage progenitors. EMBO J. 1998;17:4456–68.
Delgado MD, Hallier M, Meneceur P, Tavitian A, Moreau-Gachelin F. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides. Oncogene. 1994;9:1723–7.
Dempster AM, Snyder CA. Kinetics of granulocyte and erythroid progenitor cells are affected differently by short-term, low-level benzene exposure. Arch Toxicol 1991;65:556–61.
Du J, Stankiewicz MJ, Liu Y, et al. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem. 2002;277:43481–94.
Eichbaum QG, Iyer R, Raveh DP, Mathieu C, Ezekowitz RA. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med. 1994;179:1985–96.
Eisbacher M, Holmes ML, Newton A, et al. Protein–protein Interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocytic-specific genes through cooperative DNA binding. Mol Cel Biol. 2003;23(10):3427–41.
Fisher RC, Scott EW. Role of PU.1 in hematopoiesis. Stem Cells. 1998;16:25–37.
Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T. Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBPα, -β, and -δ during granulocyte-lineage specification. Proc Natl Acad Sci USA. 1996;93:10838–43.
Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982;60:404–11.
Gross S, Helm K, Gruntmeir J, Stillman W, Irons RD. Characterization and phenotypic analysis of differentiating CD34+ human bone marrow cells in liquid culture. Eur J Haematol. 1997;59:318–26.
Heydemann A, Juang G, Hennessy K, Parmacek MS, Simon MC. The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol Cell Biol. 1996;16:1676–86.
Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang D-E, Tenen DG. PU.1 (SPI-1) and C/EBPα regulate expression of the granulocyte macrophage colony-stimulating factor receptor α gene. Mol Cell Biol. 1995;15:5830–45.
Iida H, Towatari M, Iida M, et al. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts. Int J Hematol. 2000;71:153–8.
Irons RD. Benzene-induced myelotoxicity: application of flow cytofluorometry for the evaluation of early proliferative change in bone marrow. Environ Health Perspect. 1981;39:39–49.
Irons RD, Stillman WS. Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells. 1993;11:235–42.
Irons RD, Stillman WS. The effects of benzene and other leukaemogenic agents on haematopoietic stem and progenitor cell differentiation. Eur J Haematol. 1996a;57(Supplement 60):119–24.
Irons RD, Stillman WS. Impact of benzene metabolites on differentiation of bone marrow progenitor cells. Environ Health Perspect. 1996b;104(Supplement 6):1247–50.
Irons RD, Stillman WS. The process of leukemogenesis. Environ Health Perspect. 1996c;104:1239–46.
Irons RD, Stillman WS, Colagiovanni DB, Henry VA. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA. 1992;89:3691–5.
Li Y, Okuno Y, Zhang P, et al. Regulation of the PU.1 gene by distal elements. Blood. 2001;98:2958–65.
Lodie TA, Savedra R Jr, Golenbock DT, Van Beveren CP, Maki RA, Fenton MJ. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J Immunol. 1997;158:1848–56.
Mao C, Ray-Gallet D, Tavitian A, Moreau-Gachelin F. Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene. 1996;12:863–73.
Marden CM, Stefanidis D, Cunninghame-Graham DS, Casimir CM. Differentiation-dependent up-regulation of p47(phox) gene transcription is associated with changes in PU.1 phosphorylation and increased binding affinity. Biochem Biophys Res Commun. 2003;305:193–202.
McIvor Z, Hein S, Fiegler H, et al. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation. Exp Hematol. 2003;31:39–47.
Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998;12:2403–12.
Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood. 2000;95:2543–51.
Perez C, Coeffier E, Moreau-Gachelin F, Wietzerbin J, Benech PD. Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fcγ receptor. Mol Cell Biol. 1994;14:5023–31.
Pongubala JMR, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3' enhancer activity. Mol Cell Biol. 1992;12:368–78.
Ray-Gallet D, Mao C, Tavitian A, Moreau-Gachelin F. DNA binding specificties of Spi-1/PU.1 and Spi-B transcription factors and identification of a SPi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene. 1995;11:303–13.
Reddy VA, Iwana A, Iotzova G, et al. Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood. 2002;100:483–90.
Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13:1398–411.
Rieske P, Pongubala JM. AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J Biol Chem. 2001;276:8460–8.
Rosmarin AG, Caprio D, Levy R, Simkevich C. CD18 (β2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc Natl Acad Sci USA. 1995;92:801–5.
Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573–7.
Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996;88:1234–47.
Srikanth S, Rado, TA. PU.1 regulates the expression of the human neutrophil elastase gene. Biochim Biophys Acta. 1998;1398:215–23.
Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG. Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci USA. 1994;91: 7932–6.
Wang JM, Lai MZ, Yang-Yen HF. Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway. Mol Cell Biol. 2003;23:1896–909.
Xue Y, Alford P, Shackelford RE. Protein kinase C activation increases binding of transcription factor PU.1 in murine tissue macrophages. Biochem Biophys Res Commun. 1999;254:211–4.
Zhang D-E, Fujioka K-I, Hetherington CJ, et al. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol. 1994;14:8085–95.
Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA. 1999;96:8705–10.
Zhang P, Zhang XB, Iwama A, et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood. 2000;96:2641–48.
Zhang P, Nelson E, Radomska HS, et al. Induction of granulocytic differentiation by 2 pathways. Blood. 2002;99:4406–12.
Zheng JH, Pyatt DW, Gross SA, Le AT, Kerzic PJ, Irons RD. Hydroquinone modulates the GM-CSF signaling pathway in TF-1 cells. Leukemia. 2004;18(7):1296–304.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gross, S.A., Zheng, J.H., Le, A.T. et al. PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokine-dependent clonogenic response in human CD34+ hematopoietic progenitor cells. Cell Biol Toxicol 22, 229–241 (2006). https://doi.org/10.1007/s10565-006-0128-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-006-0128-7